Actinic Hyperkeratosis Treated with Retinol Combined with A Polylysine Biovector: A Case Report
Abstract
Background: Actinic keratosis (AK) is a precancerous skin lesion resulting from chronic exposure to ultraviolet (UV) radiation. Current treatments are effective but often perceived as aggressive, and recurrence rates remain high. This highlights the importance of developing safe products suitable for frequent use, which are non-aggressive both for the skin and for the environment. Case presentation: We report the case of a 64-year-old male patient, living in southern France, with a Mediterranean skin type (Fitzpatrick phototype IV) and advanced baldness, presenting with a chronic hyperkeratotic lesion of the scalp evolving for more than 24 months. Histological analysis confirmed actinic keratosis. The patient was treated with a dermocosmetic formulation containing retinol encapsulated in a poly-L-lysine biovector (22.5kDa), equivalent to 3.2 × 10⁶ IU of vitamin A per gram of polylysine . Application consisted of a pea-sized amount twice daily with gentle massage of the lesion. The estimated daily dose was approximately 1280 IU of vitamin A. Result and Discussion: After 21 days, the lesion regressed completely, with partial regrowth of hair at the treated site. The treatment was well tolerated, without adverse effects. This case highlights the potential of encapsulated retinol as an adjunctive strategy in the management of AK. Retinoids are known to regulate keratinocyte proliferation and differentiation, but systemic forms are limited by toxicity and teratogenicity, while…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Diagnosis and management of glutaric aciduria type I – revised recommendations
- EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
- Consensus guidelines for the diagnosis and management of pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency
- Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry
- Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
- Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.